These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1909227)

  • 1. Cost-effective use of once-daily ceftriaxone in the treatment of moderate to severe infections: introduction to a symposium.
    Andriole VT
    Chemotherapy; 1991; 37 Suppl 3():1-2. PubMed ID: 1909227
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effective use of once-daily ceftriaxone: overview of a symposium.
    Periti P
    Chemotherapy; 1991; 37 Suppl 3():26-7. PubMed ID: 1909230
    [No Abstract]   [Full Text] [Related]  

  • 3. Once-daily ceftriaxone in the outpatient treatment of paediatric infections.
    Bradley JS
    Chemotherapy; 1991; 37 Suppl 3():3-6. PubMed ID: 1884651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-daily ceftriaxone outpatient therapy in adults with infections.
    Tice AD
    Chemotherapy; 1991; 37 Suppl 3():7-10. PubMed ID: 1909231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentration of ceftriaxone in relation to the time of administration.
    Simonis G; Wolf N; Kayser M; Kalweit G; Filopoulos E
    Chemioterapia; 1987 Jun; 6(2 Suppl):264. PubMed ID: 3509407
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of acute pyelonephritis in women with intramuscular ceftriaxone: an out-patient study.
    Karachalios GN; Georgiopoulos AN; Kintziou H
    Chemotherapy; 1991; 37(4):292-6. PubMed ID: 1790728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of ceftriaxone and amikacin as single daily dose for the empirical management of febrile granulocytopenic children with cancer.
    Pession A; Prete A; Paolucci G
    Chemotherapy; 1997; 43(5):358-66. PubMed ID: 9309370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once-daily intramuscular ceftriaxone in the outpatient treatment of severe community-acquired pneumonia in children.
    Leibovitz E; Tabachnik E; Fliedel O; Steinberg S; Miskin A; Askenazi A; Barak Y
    Clin Pediatr (Phila); 1990 Nov; 29(11):634-9. PubMed ID: 2265514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and bacteriological studies of ceftriaxone (CTRX) once daily administration in pediatric patients with respiratory tract infections].
    Hasui M; Kobayashi Y; Harada Y; Ono A; Okazaki H; Kino M; Hara T
    Jpn J Antibiot; 2001 Oct; 54(10):532-40. PubMed ID: 11771335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for cost-containment: once-daily ceftriaxone plus amikacin as empiric therapy for febrile granulocytopenic children with cancer.
    Castagnola E; Lanino E; Giacchino R; Viscoli C; Dini G
    J Chemother; 1999 Feb; 11(1):54-60. PubMed ID: 10078782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once-daily ceftriaxone in the treatment of lower respiratory tract infections.
    Brown R
    Chemotherapy; 1991; 37 Suppl 3():11-4. PubMed ID: 1884650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftriaxone in treatment of serious infections. Septicemia.
    Foster MT
    Hosp Pract (Off Ed); 1991 Sep; 26 Suppl 5():43-7; discussion 62-3. PubMed ID: 1918222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of severe malnutrition with 2-day intramuscular ceftriaxone vs 5-day amoxicillin.
    Dubray C; Ibrahim SA; Abdelmutalib M; Guerin PJ; Dantoine F; Belanger F; Legros D; Pinoges L; Brown V
    Ann Trop Paediatr; 2008 Mar; 28(1):13-22. PubMed ID: 18318945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic therapy of neonates with bacterial sepsis.
    Edwards MS
    Pediatr Infect Dis J; 1995 Feb; 14(2):166-7. PubMed ID: 7746712
    [No Abstract]   [Full Text] [Related]  

  • 15. Outpatient treatment of serious community-acquired pediatric infections using once daily intramuscular ceftriaxone.
    Dagan R; Phillip M; Watemberg NM; Kassis I
    Pediatr Infect Dis J; 1987 Dec; 6(12):1080-4. PubMed ID: 3324038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of ceftriaxone monotherapy versus a combination regimen of cefuroxime plus gentamicin for treatment of serious bacterial infections: the efficacy, safety and effect on fecal flora.
    Hoepelman IM; Rozenberg-Arska M; Verhoef J
    Chemotherapy; 1988; 34 Suppl 1():21-9. PubMed ID: 3149929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-efficiency of a long-acting cephalosporin agent.
    Hall JC; Mander J; Christiansen K; Reid C; Cooney M; Gibb SM
    Aust N Z J Surg; 1988 Sep; 58(9):733-5. PubMed ID: 3150661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once-daily cefepime versus ceftriaxone for nursing home-acquired pneumonia.
    Paladino JA; Eubanks DA; Adelman MH; Schentag JJ
    J Am Geriatr Soc; 2007 May; 55(5):651-7. PubMed ID: 17493183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical studies and sputum levels of ceftriaxone once daily administration in respiratory tract infection].
    Kuwabara M; Sasaki H; Fukuhara H; Arita H; Inamizu T; Sadamoto K; Kimura T; Yamane K; Shigemoto M; Kawamoto M
    Jpn J Antibiot; 1989 Apr; 42(4):921-9. PubMed ID: 2671426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative antibacterial prophylaxis in bone surgery: sufficiently high tissue levels with ceftriaxone (rocephin) 24 hours after a single dose of 2 g.
    Rudert W; Hennecke H; Adam D
    J Chemother; 1989 Jul; 1(4 Suppl):1046-7. PubMed ID: 16312765
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.